Benefits of omalizumab on anxiety and depression in patients with severe asthma

Uzer F., ÖZBUDAK Ö.

CASPIAN JOURNAL OF INTERNAL MEDICINE, cilt.9, sa.3, ss.228-231, 2018 (ESCI) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 9 Sayı: 3
  • Basım Tarihi: 2018
  • Doi Numarası: 10.22088/cjim.9.3.228
  • Dergi Adı: CASPIAN JOURNAL OF INTERNAL MEDICINE
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus
  • Sayfa Sayıları: ss.228-231
  • Anahtar Kelimeler: Anxiety, Asthma, Depression, Omalizumab, QUALITY-OF-LIFE, DISEASE-CONTROL, DISORDERS, ADULTS, IMPACT
  • Akdeniz Üniversitesi Adresli: Evet

Özet

Background: Asthma is one of the most common chronic diseases and may cause psychiatric disorders affecting the patients' quality of life. In our study, we evaluated the effect of omalizumab treatment on anxiety disorder and depression using Beck Depression Scale (BDS) and State Trait Anxiety Inventory (STAI).